Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nobleoak LifeASX:NOL -2.13%44 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus rates ASX:NOL with a GF Score™ of 44/100 and a GF Value™ of A$1.75 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 295 Insurance companies, Nobleoak Life ranks worse than 338982.71% on this metric.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Nobleoak Life (ASX:NOL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Nobleoak Life 3-Year EBITDA Growth Rate Related Terms
ASX:NOL vs AFL, MET, PRU: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Life subindustry, Nobleoak Life's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobleoak Life 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Nobleoak Life's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Nobleoak Life's 3-Year EBITDA Growth Rate falls into.
Nobleoak Life 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Nobleoak Life (ASX:NOL) has a 3-Year EBITDA Growth Rate of 0.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Nobleoak Life and its competitors. According to the industry distribution chart, Nobleoak Life ranks #999999 out of 295 companies in the Insurance industry.
Is Nobleoak Life's 3-Year EBITDA Growth Rate too high?
Nobleoak Life's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Nobleoak Life ranks #999999 out of 295 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Nobleoak Life has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's 3-Year EBITDA Growth Rate compare to AFL and MET?
According to the Insurance industry distribution chart, Nobleoak Life ranks #999999 out of 295 companies for 3-Year EBITDA Growth Rate. This places Nobleoak Life in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 16.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 16.80, based on 295 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Nobleoak Life and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 16.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$1.75, compared to a current price of A$1.15 — trading 34.3% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Nobleoak Life's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current 3-Year EBITDA Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nobleoak Life (ASX:NOL) Overvalued in 2026?
Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued.
The current stock price of A$1.15 is trading 34.3% below its estimated GF Value™ of A$1.75.
GuruFocus considers Nobleoak Life to be Significantly Undervalued.
Key valuation signals for ASX:NOL:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: A$1.75 vs. price of A$1.15 (34.3% below fair value)
No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
44GF Score
Get the complete analysis for ASX:NOL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NOL has been successfully added to your 
